Inactive Instrument

Immunosyn Corp Share Price

Stocks

End-of-day quote Other OTC Other stock markets
- ^USD	-

30/-1/30	IMMUNOSYN CORP COM STK USD0.0001 : Immunosyn Announces Proposed Agreements for Distribution of the Biopharmaceutical SF-1019 in Utah	PR
30/-1/30	Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Corporation Files 10-Q	PR
30/-1/30	Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Corporation Announces 2007 Results, Files 10KSB	PR
30/-1/30	Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Releases Wound Healing Photographs From the First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019	PR
30/-1/30	Immunosyn Corp Com Stk Usd0.0001 : Douglas A. McClain, Jr. Resumes CFO Duties at Immunosyn	PR

Manager	Title	Age	Since
Stephen D. Ferrone CEO	Chief Executive Officer	75	15/10/2007
Douglas A. McClain DFI	Director of Finance/CFO	51	-

Director	Title	Age	Since
Stephen D. Ferrone BRD	Director/Board Member	75	09/07/2011
Douglas A. McClain CHM	Chairman	51	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
REGENERON PHARMACEUTICALS, INC.	+1.59%	+2.85%	+39.32%	-0.16%	7.83TCr
SAMSUNG BIOLOGICS CO.,LTD.	+2.77%	+4.78%	-0.98%	+26.82%	5.11TCr
UCB	+0.40%	+1.17%	+20.04%	+175.18%	4.92TCr
CSL LIMITED	+1.72%	+8.18%	-49.03%	-49.18%	4.47TCr
BIOGEN INC.	+0.80%	+2.46%	+59.13%	-23.35%	3.07TCr
INCYTE CORPORATION	+1.84%	+0.87%	+53.80%	+84.29%	2.44TCr
MODERNA, INC.	+9.86%	+7.94%	+126.53%	-41.89%	2.36TCr
INNOVENT BIOLOGICS, INC.	+2.58%	+13.14%	+8.17%	+202.17%	2.1TCr
SWEDISH ORPHAN BIOVITRUM AB	-0.82%	+3.30%	+64.98%	+114.68%	1.66TCr
Average	+1.49%	+4.08%	+35.77%	+54.28%	3.78TCr
Weighted average by Cap.	+1.28%	+4.29%	+27.06%	+42.05%

Employees

Sector